FDA OKs immune-boosting drug for advanced bladder cancer

U.S. regulators have approved a new drug that harnesses the immune system to treat advanced bladder cancer. The Food and Drug Administration on Monday approved Imfinzi (im-fin-ZEE’) along with a companion diagnostic test for identifying which patients are most likely to benefit from it. Imfinzi, also known as durvalumab, is part of a new generation […]